Business Update · Third Quarter 2022

Grifols invites investors to listen to webcast of November 8 Conference Call with Analysts

Barcelona, November 4, 2022- Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS) invites investors to listen to a webcast of a conference call with investment analysts at 2.30 pm CET /

8.30 am EST on Tuesday, November 8, 2022. The purpose of the call is to provide a business update on Grifols' results, as reflected in the company's Third Quarter 2022 Business Update

Presentation, to be issued that morning.

To listen to the webcast and view the Business Update Presentation, visit our web site www.grifols.com/en/investors. Information on accessing and registering for the webcast will be available at www.grifols.com/en/investorson Monday, November 7, 2022. Participants are advised to register in advance of the conference call.

The transcript and webcast replay of the call will be made available on our web site at www.grifols.com/investors within 24 hours after the end of the live conference call.

About Grifols

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people around the world. Its three main business units - Biopharma, Diagnostic and Bio Supplies - develop, produce and market innovative solutions and services that are sold in more than 110 countries.

Pioneers in the plasma industry, Grifols operates a growing network of donation centers worldwide. It transforms collected plasma into essential medicines to treat rare, chronic and, at times, life-threatening conditions. As a recognized leader in transfusion medicine, Grifols also offers a comprehensive portfolio of solutions designed to enhance safety from donation to transfusion. In addition, the company supplies tools, information and services that enable hospitals, pharmacies and healthcare professionals to efficiently deliver expert medical care.

Grifols, with more than 27,000 employees in more than 30 countries, is committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership.

In 2021, Grifols' economic impact in its core countries of operation was EUR 7.7 billion. The company also generated 141,500 jobs, including indirect and induced jobs.

The company's class A shares are listed on the Spanish Stock Exchange, where they are part of the Ibex- 35 (MCE:GRF). Grifols non-voting class B shares are listed on the Mercado Continuo (MCE:GRF.P) and on the U.S. NASDAQ through ADRs (NASDAQ:GRFS).

For more information about Grifols, please visit www.grifols.com

Page 1 of 1

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Grifols SA published this content on 04 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 November 2022 11:01:03 UTC.